France chooses Boehringer Ingelheim and Ceva for the 2nd wave of avian flu vaccines

Photo credit © Reuters

PARIS (Reuters) – German laboratories Boehringer Ingelheim and French Ceva Santé Animale have been chosen by France to supply the second series of avian flu vaccines in France, the companies told Reuters on Friday.

The vaccination campaign, which began last fall, made France the first country in the European Union to vaccinate poultry against this deadly virus which has led to the death of tens of millions of poultry in the country in recent years. last years.

Boehringer Ingelheim will supply 34.2 million doses under this second tender, which is for 61 million doses, the company said. Deliveries are expected to begin in April.

(Report by Sybille de La Hamaide, French version by Kate Entringer, edited by Sophie Louet)


©2024 Thomson Reuters, all rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. “Reuters” and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.

Source link -87